Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Jessica Scarborough"'
Autor:
Davis T Weaver, Kathleen I Pishas, Drew Williamson, Jessica Scarborough, Stephen L Lessnick, Andrew Dhawan, Jacob G Scott
Publikováno v:
PLoS Computational Biology, Vol 17, Iss 10, p e1008755 (2021)
MicroRNA (miRNA)-based therapies are an emerging class of targeted therapeutics with many potential applications. Ewing Sarcoma patients could benefit dramatically from personalized miRNA therapy due to inter-patient heterogeneity and a lack of drugg
Externí odkaz:
https://doaj.org/article/d3d3a5fa7c66497d85ed284850f43e42
Autor:
Wafa Asha, Sami Koro, Zachary Mayo, Kailin Yang, Ahmed Halima, Jacob Scott, Jessica Scarborough, Shauna R. Campbell, G. Thomas Budd, Dale Shepard, Kevin Stephans, Gregory M. Videtic, Chirag Shah
Publikováno v:
American Journal of Clinical Oncology. 46:263-270
Publikováno v:
Cancer Research. 83:973-973
The evolution of chemotherapeutic resistance can cause treatment failure in patients with metastatic Ewings sarcoma (EWS), a rare pediatric bone cancer. As resistance to the first-line therapy evolves, there is potential for the tumor to develop sens
Autor:
Jeremy S. Ruthberg, Armine Kocharyan, Nathan Farrokhian, Maximilian C. Stahl, Kayla Hicks, Jessica Scarborough, Gail S. Murray, Shannon Wu, Nauman Manzoor, Todd Otteson
Publikováno v:
International journal of pediatric otorhinolaryngology. 156
To reveal hearing loss patterns in patients with enlarged vestibular aqueduct (EVA) syndrome according to demographic and clinical characteristics.A retrospective, longitudinal study design was utilized to identify patients with EVA. Ears of patients
Autor:
Jessica Scarborough
Publikováno v:
TEXTILE. 17:66-71
In an early gallery talk Rowland Ricketts spoke about “the drive to make” in the face of the fact that even with human intervention, what is made will fade, will change and eventually disperse. Wit...
Publikováno v:
Cancer Research. 82:B005-B005
Evolution of chemotherapeutic resistance can cause treatment failure in patients with metastatic Ewings sarcoma (EWS). As resistance to the first-line therapy evolves, there is potential for the tumor to develop sensitivities to other chemotherapeuti